Gabelli Funds’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Gabelli Funds’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-637,908	Closed	-$30.6M	–	1109
2020 Q1	$30.6M	Buy	637,908 +244,517	+62%	+$11.4M	0.27%	100
2019 Q4	$18.5M	Buy	+393,391	New	+$17.4M	0.12%	233
2018 Q4	–	Sell	-12,037	Closed	-$218K	–	1166
2018 Q3	$218K	Hold	12,037	–	–	﹤0.01%	1097
2018 Q2	$120K	Buy	+12,037	New	+$83.1K	﹤0.01%	1127

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Gabelli Funds's RARX Position: Q2 2020 in Review

Gabelli Funds sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 637,908 shares — an estimated $30.6M sold.

Gabelli Funds first reported a position in RARX in Q2 2018 and held it in 4 quarters. The position peaked at $30.6M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Gabelli Funds reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Gabelli Funds sold 637,908 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $30.6M.
Gabelli Funds first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
Gabelli Funds's Ra Pharmaceuticals, Inc. Common Stock position peaked at $30.6M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Gabelli Funds's 13F filing for Q2 2020, filed 13 Aug 2020.